Key Takeaways
- Conference Pop: Tempus A stock jumped 11% on Tuesday, September 15, closing at $69 as CEO Eric Lefkofsky took the stage at Morgan Stanley’s healthcare conference.
- Street Gets Passed: Nineteen analysts split 8 buys, 2 outperforms, 8 holds and 1 sell, and the $68 mean target now sits 1% below the stock’s new close.
- Coverage Build: Price-target coverage grew from 10 analysts to 17 over five quarters.
- September Momentum: The rally followed a $9.5 million ARPA-H cardiology-AI award on September 9 and a 100,000-genome dataset launch on September 11.
Why Tempus AI Stock Jumped 11% at a Healthcare Conference
Tempus AI (TEM) stock jumped 11% on Tuesday, September 15, closing at $69 as CEO Eric Lefkofsky took the stage for a fireside chat at Morgan Stanley’s 24th Annual Global Healthcare Conference.
The company had spent the prior week stacking evidence behind its AI platform story. On September 9, Tempus disclosed it had won up to $9.5 million in ARPA-H funding to build an autonomous AI agent for heart-failure care. Two days later, it launched an initiative to compile 100,000 disease-specific whole-genome sequences tied to real patient outcomes, with a long-term target of 1 million genomes. Both initiatives sit inside the data and AI-agent segments that have anchored the bull case since Tempus agreed in July to buy cancer-monitoring firm Personalis for $1.5 billion. Lefkofsky’s fireside chat gave investors a stage to hear those threads pulled into one story, and Tempus AI stock built on that momentum into the close.
The rally does more than add one green day to the chart: it pushes Tempus AI stock past the level where the Street, on average, currently prices the business, and that gap is what the numbers below have to answer.
Tempus AI Stock Now Trades Above the Street’s Own Target
Nineteen analysts cover Tempus AI stock, split 8 buys, 2 outperforms, 8 holds and 1 sell. Their mean target sits at $68, a dollar below where the stock closed on Tuesday, putting the average forecast 1% behind the new price instead of ahead of it.
The dispersion below that $68 average is wide: the high target sits at $100, implying 45% upside from Tuesday’s close, while the low sits at $35, implying 49% downside, the widest bull-bear split yet. A mean built from that wide a range signals real disagreement among analysts about what Tempus AI stock is worth.
That 1% gap is a reversal from where this relationship stood three quarters ago. In December 2025, the mean target sat at $89 against a $59 close, a 51% spread, even as the stock was sliding from the $81 level it held in September 2025. Tempus AI stock kept falling into March 2026, bottoming near $45 while the target held at $75, a 67% premium that marked the widest gap of the stretch. From there both lines converged: the stock climbed to $58 by June and now sits at $69, while the mean target got trimmed to $66, then $68. Analysts issuing price targets grew from 10 in June 2025 to 17 now. The buy count rose from 4 to 8 over that same stretch, even as a lone sell rating first appeared in June 2026 and has stuck around since.
That leaves Tempus AI stock trading in the one place the Street had not reached before Tuesday, ahead of its own average forecast, with the next round of estimate revisions the thing to watch.
Should You Invest in Tempus AI, Inc.?
The only way to really know is to look at the numbers yourself. TIKR gives you free access to the same institutional-quality financial data that professional analysts use to answer exactly that question.
Pull up Tempus AI, Inc. stock and you’ll see years of historical financials, what Wall Street analysts expect for revenue and earnings in the quarters ahead, how valuation multiples have moved over time, and whether price targets are trending up or down.
You can build a free watchlist to track Tempus AI, Inc. alongside every other stock on your radar. No credit card required. Just the data you need to decide for yourself.
Access Professional Tools to Analyze TEM stock on TIKR for Free →
Looking for New Opportunities?
- See what stocks billionaire investors are buying so you can follow the smart money.
- Analyze stocks in as little as 5 minutes with TIKR’s all-in-one, easy-to-use platform.
- The more rocks you overturn… the more opportunities you’ll uncover. Search 100K+ global stocks, global top investor holdings, and more with TIKR.
Disclaimer:
Please note that the articles on TIKR are not intended to serve as investment or financial advice from TIKR or our content team, nor are they recommendations to buy or sell any stocks. We create our content based on TIKR Terminal’s investment data and analysts’ estimates. Our analysis might not include recent company news or important updates. TIKR has no position in any stocks mentioned. Thank you for reading, and happy investing!
